LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat breast cancer: drug combo trial launches
Disease control Recruiting nowThis phase 3 trial tests whether a new drug (HRS-8080) combined with dalpiciclib works better than a standard drug (fulvestrant) combined with dalpiciclib for people with advanced breast cancer that no longer responds to hormone therapy. About 912 women aged 18-75 with locally ad…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:03 UTC
-
New hope for advanced breast cancer: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug combination (SIM0270 plus everolimus) against standard treatments for people with a certain type of advanced breast cancer (ER+/HER2-) that has worsened after prior therapy. About 460 participants will be randomly assigned to receive either the new com…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New hope for advanced breast cancer: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug called SPH4336 combined with hormone therapy for people with a certain type of advanced breast cancer (HR-positive, HER2-negative) that has gotten worse after standard treatment. About 254 participants will receive the combination to see if it shrinks …
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated May 22, 2026 14:02 UTC